Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 1064

Results For "C"

11240 News Found

Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
People | June 02, 2026

Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing

Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide


Zydus’ Saroglitazar wins FDA priority review after strong Phase 3 results in liver disease trial
Drug Approval | June 01, 2026

Zydus’ Saroglitazar wins FDA priority review after strong Phase 3 results in liver disease trial

The therapy also delivered significant improvements in key liver enzyme markers


Pfizer and FITT IIT Delhi identify 20 health startups under innovation programme
R&D | June 01, 2026

Pfizer and FITT IIT Delhi identify 20 health startups under innovation programme

Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations


Alkem Labs posts highest-ever EBITDA in FY26; Q4 revenue rises 14.6%
News | May 29, 2026

Alkem Labs posts highest-ever EBITDA in FY26; Q4 revenue rises 14.6%

Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit


Organ Man of India Nilesh Mandlewala bestowed with Padma Shri
Healthcare | May 28, 2026

Organ Man of India Nilesh Mandlewala bestowed with Padma Shri

Honoured for his immense contribution in the field of social service and organ donation awareness


Morepen Labs posts strong Q4 FY26 net profit
News | May 28, 2026

Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore


Gandhar Oil posts robust FY26 profit
News | May 28, 2026

Gandhar Oil posts robust FY26 profit

PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion


SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth
News | May 25, 2026

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore


Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial
Clinical Trials | May 23, 2026

Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial

Clears major obesity endpoints at 80 weeks